
Unitree Robotics, the Hangzhou-based maker of humanoid and quadruped robots, has priced its initial public offering on the Shanghai Stock Exchange at about $22 per share, seeking to raise around $900 million…
Unitree Robotics, the Hangzhou-based maker of humanoid and quadruped robots, has priced its initial public offering on the Shanghai Stock Exchange at about $22 per share, seeking to raise around $900 million at a valuation of roughly $9 billion, The New York Times reports. The company shipped more humanoid robots than any other manufacturer last year and generated $250 million in revenue in 2025, with sales quadrupling and the firm turning profitable.

However, profit dropped 55% in the first quarter of 2026 due to competitive pressure and higher R&D spending, the Times reports. The IPO is the first by a humanoid robotics firm on mainland China's bourse and is seen as a key test of investor appetite for the sector. Chinese manufacturers shipped about 18,500 humanoid robots in the first half of this year against around 4,000 by US firms, giving China a production lead, Omdia estimates.
The $9 billion valuation narrative paints China as the undisputed factory-floor leader in humanoids, but the 55% profit plunge reveals how thin margins are when you race to ship units before demand firms up. The real question is not who builds more robots, China clearly does, but whether anyone can sell them at scale to factories or households. Watch the IPO's aftermarket trading: if the stock sags despite China's production boast, the market will have delivered its verdict on hype over hard commercial maths.
Sources (2): hindustantimes.com, ndtvprofit.com
This story was synthesised by AI from the 2 sources linked above.
Updated: this story now draws on 2 sources.